The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187.
Phillips 66
PSX · a US exchange · USD · Market cap $97.8B · 12,600 employees
Phillips 66 operates as an integrated downstream energy provider in the United States, the United Kingdom, Germany, and internationally.
PASS · Titan Ethical · score 79.9Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price242.71 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 17 Nov 2026
- Ethical screenPasses, score 79.9 out of 100
- OptionsOpen interest leans to puts (put/call 2.93)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $204.56 to $340.94, base estimate $284.88 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 2.93, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Phillips 66 holds its Distribution at $242.71. The statistical read favours the sellers, held for 4 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 4 days |
| Price at the screen | $242.71 |
| Valuation | 8.04 trailing · 7.77 forward price to earnings |
| Values screen | PASS · score 79.9 |
| Beta | 0.67 |
Five Screens: PSX's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 26.76% | Below 33% | Pass |
| Interest-bearing cash | 15.75% | Below 33% | Pass |
| Receivables | 14.78% | Below 49% | Pass |
| Revenue purity | 0.11% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Phillips 66 clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PSX's ethical verdict changes
Today PSX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 15% discount to our $284.88 fair value, weak competitive moat, 46.40% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 14.8% discount to the base estimate.
Third-party analyst targets: 19 covering, consensus Buy. The average target sits +22% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $284.88, with a range of $204.56 to $340.94, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsRefining margins look tempting until they vanish
Picture a petrol station forecourt where pump prices swing with every tanker that docks. Phillips 66 sits right in that chain, turning crude into fuel and chemicals across five segments. It trades at 11.5 times forward earnings with 7 percent revenue growth and 15 percent ROE, numbers that appear attractive on the surface.
The business passes our ethical screen and draws buy ratings from most analysts. Yet refining is a classic cyclical activity where earnings peak just as multiples compress. A weak moat and 3 percent profit margin leave little cushion when demand or feedstock costs turn.
Our fair value sits 14 percent below the current price. That gap, combined with the risk of peak-cycle earnings, points to a value trap rather than a bargain. Analysis, not advice.
| Forward P/E | 7.8xcheap for a company growing this fast |
| Trailing P/E | 8.0xvery cheap relative to earnings |
| EPS, trailing | 31.18 |
| EPS, forward | 32.28 |
| Revenue growth | +46.4%growing very fast |
| Profit margin | 7.5%thin but positive margins |
| Return on equity | 39.8%an exceptional return on shareholder capital |
| FCF yield | 9.73% |
| Dividend yield | 2.07% |
| Debt to equity | 0.52moderate, manageable leverage |
| Current ratio | 1.34adequate liquidity, worth monitoring |
| Beta | 0.67steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 127.16 - 299.39 |
| Moat | WEAK |
| Market cap | $97.8B |
| Employees | 12,600 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. Since the last review it its composite score rose.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Your Chevron Hedge Works Only While Oil Spikes Yahoo Finance · 18h ago
- Phillips 66 Expands Arkestro's Predictive Procurement Platform Across Enterprise Yahoo Finance · 18h ago
- Valero Energy vs. Phillips 66: Which is the Stronger Refining Player? Yahoo Finance · 21h ago
- What Moved Marathon Petroleum Stock? Yahoo Finance · 21h ago
- What Sent Valero Energy Stock Lower? Yahoo Finance · 21h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Mandell Brian | EVP | S - Sale+OE | 23,400 | $6,202,381 |
| 2026-05-11 | MITCHELL KEVIN J | Chief Financial Officer | 30,000 | $5,101,083 | |
| 2026-05-11 | MITCHELL KEVIN J | Chief Financial Officer | 30,000 | $2,848,390 | |
| 2026-05-06 | MEYERS KEVIN OMAR | Director | 175 | $30,297 | |
| 2026-03-30 | MITCHELL KEVIN J | Chief Financial Officer | 15,629 | $2,970,546 | |
| 2026-03-30 | MITCHELL KEVIN J | Chief Financial Officer | 15,629 | $1,484,247 | |
| 2026-03-17 | MEYERS KEVIN OMAR | Director | 175 | $30,310 | |
| 2026-03-16 | UNGERLEIDER HOWARD I. | Director | 949 | $164,023 | |
| 2026-03-16 | MEYERS KEVIN OMAR | Director | 949 | $164,023 | |
| 2026-03-13 | DAVIS LISA ANN | Director | 3,800 | $662,617 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $174.10 | +4.6% | $1.27 | $1,053 | +5.3% |
| 2 months | $158.10 | +15.2% | $1.27 | $1,160 | +16.0% |
| 3 months | $172.84 | +5.3% | $1.27 | $1,061 | +6.1% |
| 6 months | $141.24 | +28.9% | $2.54 | $1,307 | +30.7% |
| 1 year | $114.77 | +58.6% | $4.94 | $1,629 | +62.9% |
| 2 years | $128.86 | +41.3% | $9.59 | $1,487 | +48.7% |
| 3 years | $89.10 | +104.3% | $13.89 | $2,199 | +119.9% |
| 5 years | $75.32 | +141.7% | $21.64 | $2,705 | +170.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PSX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.